WIProud on MSN
UW Eau Claire PD adds Therapy K9 to the team
The University of Wisconsin-Eau Claire Police Department has a recruit who is winning hearts with puppy dog eyes and a ...
The addition of the immune checkpoint inhibitor Tecentriq (atezolizumab) to neoadjuvant chemotherapy and as a single agent ...
Mocha, a 10-week-old Labradoodle, is training to become the University of Wisconsin-Eau Claire Police Department's first ...
GlobalData on MSN
EC approves Roche’s Gazyva to treat active lupus nephritis
Roche has received EC approval for its humanised monoclonal antibody Gazyva, in combination with mycophenolate mofetil (MMF).
Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.
General-purpose AI chatbots (e.g., ChatGPT, Claude, Gemini)—designed for broad assistance and conversation, not therapy: They ...
Giving Tuesday starts in less than 24 hours and the University of Wisconsin Eau Claire is asking for your help to raise money for its new police therapy dog.
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease ...
UW-Eau Claire is participating in Giving Tuesday, a global movement that encourages people to give back to their community.
Regeneron said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease ...
Pharmaceutical Technology on MSN
Alvotech and Advanz announce EC approval for Gobivaz biosimilar
Alvotech and Advanz Pharma have announced the European Commission’s (EC) marketing authorisations for Gobivaz, a biosimilar to Simponi (golimumab), across the European Economic Area (EEA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results